top of page
This site was designed with the
.com
website builder. Create your website today.Start Now
Books On Shelf

Publications

Enteral administration of the protease inhibitor gabexate mesilate preserves vascular function in experimental trauma/hemorrhagic shock

J D Moreira N, Dos Santos F, Li JB, Aletti F, Irigoyen MCC, Kistler EB.​

Sci Rep. 2023 Jun 22;13(1):10148. doi: 10.1038/s41598-023-36021-7.

Plasma enzymatic activity, proteomics and peptidomics in COVID-19-induced sepsis: A novel approach for the analysis of hemostasis

Dos Santos F, Li JB, Juocys N, Mazor R, Beretta L, Coufal NG, Lam MTY, Odish MF, Irigoyen MC, O'Donoghue AJ, Aletti F, Kistler EB.

Front Mol Biosci. 2023 Jan 11;9:1051471. doi: 10.3389/fmolb.2022.1051471. eCollection 2022.

Efficacy of Tranexamic Acid in Blood Versus Crystalloid-Resuscitated Trauma/Hemorrhagic Shock

Dos Santos F, Li JB, Mazor R, Aletti F, Kistler EB.

J Surg Res. 2022 Nov;279:89-96. doi: 10.1016/j.jss.2022.05.028. Epub 2022 Jun 22.

Enteral gabexate mesilate improves volume requirements and autonomic cardiovascular function after experimental trauma/hemorrhagic shock in the absence of blood reperfusion

Dos Santos F, Li JB, Moreira NJ, Mazor R, Aletti F, Kistler EB.

Am J Transl Res. 2022 Oct 15;14(10):7391-7402. eCollection 2022.

Continuous enteral protease inhibition as a novel treatment for experimental trauma/hemorrhagic shock

Aletti F, DeLano FA, Maffioli E, Mu H, Schmid-Schönbein GW, Tedeschi G, Kistler EB.

Eur J Trauma Emerg Surg. 2022 Jun;48(3):1579-1588. doi: 10.1007/s00068-020-01591-y. Epub 2021 Jan 22.

Involvement of Toll-Like Receptor 4 in Decreased Vasopressor Response Following Trauma/Hemorrhagic Shock

Mazor R, Dos Santos F, Li JB, Aletti F, Schmid-Schonbein G, Kistler EB.

Crit Care Explor. 2021 Jul 6;3(7):e0469. doi: 10.1097/CCE.0000000000000469. eCollection 2021 Jul.

Resuscitation from hemorrhagic shock after traumatic brain injury with polymerized hemoglobin

Muller CR, Courelli V, Lucas A, Williams AT, Li JB, Dos Santos F, Cuddington CT, Moses SR, Palmer AF, Kistler EB, Cabrales P.

Sci Rep. 2021 Jan 28;11(1):2509. doi: 10.1038/s41598-021-81717-3.

Enteral Tranexamic Acid Decreases Proteolytic Activity in the Heart in Acute Experimental Hemorrhagic Shock

Aletti F, Santamaria M, Chin K, Mazor R, Kistler EB.

J Cardiovasc Pharmacol Ther. 2019 Sep;24(5):484-493. doi: 10.1177/1074248419841630. Epub 2019 Apr 29.

Enteral tranexamic acid attenuates vasopressor resistance and changes in α1-adrenergic receptor expression in hemorrhagic shock

Santamaria MH, Aletti F, Li JB, Tan A, Chang M, Leon J, Schmid-Schönbein GW, Kistler EB.

J Trauma Acute Care Surg. 2017 Aug;83(2):263-270. doi: 10.1097/TA.0000000000001513.

In vivo analysis of intestinal permeability following hemorrhagic shock

Alsaigh T, Chang M, Richter M, Mazor R, Kistler EB.

World J Crit Care Med. 2015 Nov 4;4(4):287-95. doi: 10.5492/wjccm.v4.i4.287. eCollection 2015 Nov 4.

bottom of page